Logo

Amoy Diagnostics

In Brief This Week: Grail, Illumina, Veracyte, Aspira Women's Health, and More

News items for the in vitro diagnostics industry for the week of March 15, 2021.

AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance

The companies have worked together on a number of other cancer-related projects, including a companion diagnostic for the ovarian cancer treatment olaparib.

Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China

AmoyDx will develop and seek regulatory approval in China for a lung cancer PCR panel to be used with Merck's MET inhibitor tepotinib.

Amoy Diagnostics, Haihe Pharmaceutical Ink Agreement to Codevelop CDx for Lung Cancer Treatment

Amoy will develop its AmoyDx Pan Lung Cancer PCR Panel (9-in-1 Plus) as a companion diagnostic test for Haihe's MET kinase inhibitor Glumetinib.

AmoyDx Strikes CDx Development Deal for Merck KGaA Cancer Drug

AmoyDx aims to develop a companion diagnostic for Merck KGaA's non-small cell lung cancer treatment Tepmetko, which was recently approved in Japan.